PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma.
Clinical and experimental medicine 2019 Oct .
Kasamatsu Tetsuhiro, Awata Maaya, Ishihara Rei, Murakami Yuki, Gotoh Nanami, Matsumoto Morio, Sawamura Morio, Yokohama Akihiko, Handa Hiroshi, Tsukamoto Norifumi, Saitoh Takayuki, Murakami Hiroka
CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens.
Annals of hematology 2018 Mar 97 (3): 485-495.
Qin Xiao-Ying, Lu Jin, Li Guo-Xuan, Wen Lei, Liu Yang, Xu Lan-Ping, Chang Ying-Jun, Liu Kai-Yan, Jiang Zheng-Fan, Huang Xiao-J